Cite
HARVARD Citation
Kamphuis, E. et al. (2022). Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology. 33 (12), p. n/a. [Online].